Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research
You may also like
Andrew Beggs, Mike Hubank and Matt Loose
Jose Afonso Guerra-Assuncao, Research Associate, UCL
Sam Rodriques, Group Leader, Francis Crick Institute
Sarah Teichmann, Cellular Genetics Programme Head, Wellcome Sanger Institute
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
Charles Swanton, Senior Group Leader, Crick Institute
Peter Johnson, National Clinical Director for Cancer, NHS England
Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research
Featuring speakers from GSK and the University of Oxford
Heidi Rehm, Chief Genomics Officer, Centre for Genomic Medicine and Co-Director, Medical and Population Genetics, Massachesetts General Hospital and Broad Institute
